Merck KGaA (ETR:MRK)
127.70
-0.70 (-0.55%)
At close: Jan 23, 2026
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
€341,177
Profits / Employee
€47,413
Market Cap
55.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 59,020 | -3,888 | -6.18% | 59,020 | 0 |
| Dec 31, 2023 | 62,908 | -1,324 | -2.06% | 62,908 | 0 |
| Dec 31, 2022 | 64,232 | 3,898 | 6.46% | 64,232 | 0 |
| Dec 31, 2021 | 60,334 | 2,207 | 3.80% | 60,334 | 0 |
| Dec 31, 2020 | 58,127 | 1,056 | 1.85% | 55,221 | 2,906 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
| SCHOTT Pharma AG & Co. KGaA | 4,811 |
Merck KGaA News
- 4 days ago - EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 9 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 12 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor - Benzinga
- 17 days ago - MilliporeSigma: Curiosity Cub Completes 2025 Tour, Inspiring Future Innovators Through AI - Finanz Nachrichten
- 4 weeks ago - Merck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor - Finanz Nachrichten
- 5 weeks ago - Why Immunome, A Top 3% Stock, Just Rocketed On Its Rivalry With Merck KGaA - Investor's Business Daily
- 5 weeks ago - Thin-Film Electrode Market worth $0.97 billion by 2030 at 11.3%, says MarketsandMarkets™ - Benzinga